Women in Medicine Month, Part II
September 11, 2019
September is Women in Medicine Month. Read about the achievements and talents of some of UT Health San Antonio’s women faculty in the second in a series of newsletters. View the newsletter
Novel therapy developed for inherited breast cancer
September 10, 2019
UT Health San Antonio researchers have discovered a novel way to kill cancers that are caused by an inherited mutation in BRCA1, the type of cancer for which actress Angelina Jolie had preventive double mastectomy and reconstructive surgery in 2013. “This represents a new treatment for inherited breast and ovarian cancer, which are higher in […]
FDA approves new drug to treat a rare blood cancer
September 10, 2019
The U.S. Food and Drug Administration recently approved the first new medication in nearly a decade for patients with myelofibrosis, a rare blood cancer. Ruben Mesa, M.D., FACP, director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was part of the international research team that led development of […]
New head of cardiology named
September 10, 2019
UT Health San Antonio has recruited Allen S. Anderson, M.D., FACC, FAHA, to direct and expand the university’s many initiatives in cardiology and cardiovascular disease education and research. Dr. Anderson is a nationally recognized leader in heart failure and cardiac transplantation at the Northwestern University Feinberg School of Medicine in Chicago. On Nov. 1, he […]
Women in Medicine Month
September 4, 2019
September is Women in Medicine Month. Read about the achievements and talents of some of UT Health San Antonio’s women faculty in the first in a series of newsletters. View the newsletter
UT Health scientist continues study of children’s cancer using new grant to predict drug responses from genomic data
August 28, 2019
The largest award, $892,157, went to Yidong Chen, Ph.D., a professor of population health sciences in the Joe R. and Teresa Lozano Long School of Medicine.